Literature DB >> 12911850

In-hospital initiation of statin therapy in patients with acute coronary events.

Gregg C Fonarow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12911850     DOI： 10.1007/s11883-003-0011-4

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  48 in total

1.  In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now.

Authors:  G C Fonarow; C M Ballantyne
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

2.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP).

Authors:  G C Fonarow; A Gawlinski; S Moughrabi; J H Tillisch
Journal:  Am J Cardiol       Date:  2001-04-01       Impact factor: 2.778

Review 3.  The value of lowering cholesterol after myocardial infarction.

Authors:  J E Rossouw; B Lewis; B M Rifkind
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

4.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Authors: 
Journal:  JAMA       Date:  1993-06-16       Impact factor: 56.272

5.  Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.

Authors:  H D Aronow; E J Topol; M T Roe; P L Houghtaling; K E Wolski; A M Lincoff; R A Harrington; R M Califf; E M Ohman; N S Kleiman; M Keltai; R G Wilcox; A Vahanian; P W Armstrong; M S Lauer
Journal:  Lancet       Date:  2001-04-07       Impact factor: 79.321

6.  Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.

Authors: 
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

7.  Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease.

Authors:  C A Sueta; M Chowdhury; S J Boccuzzi; S C Smith; C M Alexander; A Londhe; A Lulla; R J Simpson
Journal:  Am J Cardiol       Date:  1999-05-01       Impact factor: 2.778

8.  The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.

Authors:  T A Pearson; I Laurora; H Chu; S Kafonek
Journal:  Arch Intern Med       Date:  2000-02-28

9.  Strategies for implementing lipid-lowering therapy: pharmacy-based approach.

Authors:  K K Birtcher; C Bowden; C M Ballantyne; M Huyen
Journal:  Am J Cardiol       Date:  2000-02-10       Impact factor: 2.778

10.  Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention.

Authors:  C B Taylor; N Houston-Miller; J D Killen; R F DeBusk
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391
View more
  1 in total

1.  Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective.

Authors:  Jorge Yarzebski; Edgard Granillo; Frederick A Spencer; Darleen Lessard; Jerry H Gurwitz; Joel M Gore; Robert J Goldberg
Journal:  Int J Cardiol       Date:  2008-01-16       Impact factor: 4.164
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.